The Petri Dish: Startup behind VR treatments gets $16M, Aldeyra notches midstage trial win

A Cambridge-based startup that won FDA approval in 2021 for a digital treatment for lazy eye brought in $16 million in a Series A round, and other life sciences news you may have missed.